Elizabeth Stoner - Concepedia

Author

Elizabeth Stoner

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

ELIZABETH STONER, Elizabeth A. Stoner, Elizabeth Stoner, Elizabeth. Stoner, Stoner, Elizabeth

Publications

5.3K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Cornell University NewYork–Presbyterian Hospital Johns Hopkins University Dalhousie University

About

Elizabeth Stoner is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, urology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	2K
2	Engineering	2	2	77
3	Public Health	1	1	32
4	Social Sciences	1	1	16
5	Behavioral Sciences	1	1	16

Elizabeth Stoner

Publications

Citations

H-Index

Page 1

	Year	Citations
The Effect of Finasteride in Men with Benign Prostatic Hyperplasia Glenn J. Gormley, Elizabeth Stoner, Reginald C. Bruskewitz, New England Journal of Medicine	1992	1.1K
Genotyping Steroid 21-Hydroxylase Deficiency: Hormonal Reference Data* Maria I. New, F Lorenzen, Alan J. Lerner, The Journal of Clinical Endocrinology & Metabolism Adrenal GlandUrology21-Oh DeficiencyAdrenal Health21-Oh Deficiency Genotype	1983	641
Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency Tinh‐Hai Collet, B. Dubern, Jacek Mokrosiński, Molecular Metabolism	2017	286
Late-Onset Adrenal Steroid 3β-Hydroxysteroid Dehydrogenase Deficiency. I. A Cause of Hirsutism in Pubertal and Postpubertal Women* Songya Pang, Alan J. Lerner, Elizabeth Stoner, The Journal of Clinical Endocrinology & Metabolism	1985	240
Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia Elizabeth Stoner Urology UrologyEfficacy DataPharmacologyThree-year SafetyBenign Prostatic Hyperplasia	1994	207
The Clinical Effects of a 5α-Reductase Inhibitor, Finasteride, on Benign Prostatic Hyperplasia Elizabeth Stoner The Journal of Urology	1992	166
Effects of Finasteride (MK-906), a 5<i>α</i>-Reductase Inhibitor, on Circulating Androgens in Male Volunteers* Glenn J. Gormley, Elizabeth Stoner, Roger S. Rittmaster, The Journal of Clinical Endocrinology & Metabolism	1990	161
THE LONG‐TERM EFFECTS OF FUNCTIONAL COMMUNICATION TRAINING IN HOME SETTINGS K. Mark Derby, David P. Wacker, Wendy Berg, Journal of Applied Behavior Analysis	1997	147
The Syndrome of Apparent Mineralocorticoid Excess: Its Association with 1 lβ –Dehydrogenase and 5β –Reductase Deficiency and Some Consequences for Corticosteroid Metabolism* Carl Monder, Cedric Shackleton, H. Leon Bradlow, The Journal of Clinical Endocrinology & Metabolism	1986	144
The Effect of Finasteride on Prostate Specific Antigen: Review of Available Data Harry A. Guess, Glenn J. Gormley, Elizabeth Stoner, The Journal of Urology	1996	128

Page 1